NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 213 filers reported holding NOVAVAX INC in Q2 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,123,461 | -55.5% | 88,741 | +158.7% | 0.12% | +15.0% |
| Q1 2022 | $2,527,000 | +199.1% | 34,308 | +481.1% | 0.10% | +284.6% |
| Q4 2021 | $845,000 | -37.3% | 5,904 | -9.2% | 0.03% | -40.9% |
| Q3 2021 | $1,348,000 | -39.6% | 6,500 | -47.2% | 0.04% | -44.3% |
| Q1 2021 | $2,230,000 | +39.0% | 12,300 | -14.5% | 0.08% | +43.6% |
| Q4 2020 | $1,604,000 | -34.8% | 14,386 | -36.7% | 0.06% | -32.1% |
| Q3 2020 | $2,461,000 | +34.4% | 22,717 | +3.4% | 0.08% | +62.0% |
| Q2 2020 | $1,831,000 | – | 21,960 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,002,087 | $544,308,000 | 8.21% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 323,517 | $58,657,000 | 7.86% |
| Samsara BioCapital, LLC | 198,600 | $36,008,000 | 6.64% |
| Foresite Capital Management I, LLC | 66,810 | $12,113,000 | 6.11% |
| Foresite Capital Management II, LLC | 67,373 | $12,215,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 191,200 | $34,666,000 | 2.63% |
| Rock Springs Capital Management LP | 461,000 | $83,584,000 | 1.82% |
| TSP Capital Management Group, LLC | 23,525 | $4,265,000 | 1.50% |
| Ikarian Capital, LLC | 195,700 | $35,483,000 | 1.19% |
| SevenOneSeven Capital Management | 1,744 | $316,000 | 1.16% |